JPMorgan Chase & Co’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $417K | Buy |
287,743
+22,642
| +9% | +$32.8K | ﹤0.01% | 4143 |
|
|
2025
Q1 | $366K | Buy |
265,101
+198,345
| +297% | +$274K | ﹤0.01% | 4184 |
|
|
2024
Q4 | $203K | Buy |
66,756
+34,951
| +110% | +$106K | ﹤0.01% | 4526 |
|
|
2024
Q3 | $158K | Buy |
31,805
+15,441
| +94% | +$76.9K | ﹤0.01% | 4554 |
|
|
2024
Q2 | $95.7K | Sell |
16,364
-50,649
| -76% | -$296K | ﹤0.01% | 4616 |
|
|
2024
Q1 | $532K | Buy |
67,013
+33,783
| +102% | +$268K | ﹤0.01% | 3919 |
|
|
2023
Q4 | $194K | Buy |
+33,230
| New | +$194K | ﹤0.01% | 4459 |
|
|
2022
Q2 | – | Sell |
-361
| Closed | -$1K | – | 5903 |
|
|
2022
Q1 | $1K | Buy |
+361
| New | +$1K | ﹤0.01% | 5663 |
|